HIPK2 sustains apoptotic response by phosphorylating Che-1/AATF and promoting its degradation

Cell Death and Disease

Volumn 5, Issue 9, 2014, Pages

  De Nicola, F ^a   Catena, V ^a,b   Rinaldo, C ^a,c   Bruno, T ^a   Iezzi, S ^a   Sorino, C ^a   Desantis, A ^a   Camerini, S ^d   Crescenzi, M ^d   Floridi, A ^a   Passananti, C ^c   Soddu, S ^a   Fanciulli, M ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CARRIER PROTEINS AND BINDING PROTEINS; CHE 1 PROTEIN; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; PEPTIDYLPROLYL ISOMERASE PIN1; PROTEIN MDM2; UNCLASSIFIED DRUG; AATF PROTEIN, HUMAN; APOPTOSIS REGULATORY PROTEIN; CARRIER PROTEIN; HIPK2 PROTEIN, HUMAN; PROTEIN BINDING; PROTEIN SERINE THREONINE KINASE; REPRESSOR PROTEIN; UBIQUITIN;

APOPTOSIS; ARTICLE; AUTOPHOSPHORYLATION; CELL CYCLE ARREST; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DNA DAMAGE; HCT116 CELL LINE; HEK293 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; UBIQUITINATION; GENETICS; METABOLISM; PHOSPHORYLATION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARRIER PROTEINS; DNA DAMAGE; HUMANS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; PROTEOLYSIS; REPRESSOR PROTEINS; UBIQUITIN; UBIQUITINATION;

EID: 84927157382     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.381     Document Type: Article

References (39)

1. Fanciulli M, Bruno T, Di Padova M, De Angelis R, Iezzi S, Iacobini C et al. Identification of a novel partner of RNA polymerase II subunit 11, Che-1, which interacts with and affects the growth suppression function of Rb. FASEB J 2000; 14: 904-912.
2. Thomas T, Voss AK, Petrou P, Gruss P. The murine gene, Traube, is essential for the growth of pre-implantation embryos. Dev Biol 2000; 227: 324-342.
3. Lindfors K, Halttunem T, Houtari P, Nupponen N, Vihinen M, Visakorpi T et al. Identification of novel transcription factor-like gene from human intestinal cells. Biochem Biophys Res Commun 2000; 276: 660-666.
4. Page G, Lodige I, Kogel D, Scheidtmann KH. AATF a novel transcription factor that interacts with Dlk/ZIP kinase and interferes with apoptosis. FEBS Lett 1999; 462: 187-191.
5. Burgdorf S, Leister P, Scheidtmann KH. TSG101 interacts with AATF and enhances AR-mediated transcription by promoting its mono-ubiquitination. J Biol Chem 2004; 279: 17524-17534.
6. Bruno T, De Angelis R, De Nicola F, Barbato C, Di Padova M, Corbi N et al. Che-1 affects cell growth by interfering with the recruitment of HDAC1 by Rb. Cancer Cell 2002; 2: 387-399.
7. Bruno T, De Nicola F, Iezzi S, Lecis D, D'Angelo C, Di Padova M et al. Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint. Cancer Cell 2006; 10: 473-486.
8. Bacalini MG, Di Lonardo D, Catizone A, Ciccarone F, Bruno T, Zampieri M et al. Poly (ADP-ribosyl)ation affects stabilization of Che-1 protein in response to DNA damage. DNA Repair (Amst) 2011; 10: 380-389.
9. De Nicola F, Bruno T, Iezzi S, Di Padova M, Floridi A, Passananti C et al. The propyl isomerase Pin1 affects Che-1 stability in response to apoptotic DNA damage. J Biol Chem 2007; 282: 19685-19691.
10. Höpker K, Hagmann H, Khurshid S, Chen S, Hasskamp P, Seeger-Nukpezah T et al. AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosis. EMBO J 2012; 31: 3961-3975.
11. Barbato C, Corbi N, Canu N, Fanciulli M, Serafino A, Ciotti M et al. Rb binding protein Che-1 interacts with Tau in cerebellar granule neurons. Modulation during neuronal apoptosis. Mol Cell Neurosci 2003; 24: 1038-1050.
12. Guo Q, Xie J. AATF inhibits aberrant production of amyloid beta peptide 1-42 by interacting directly with Par-4. J Biol Chem 2004; 279: 4596-4603.
13. Di Certo MG, Corbi N, Bruno T, Iezzi S, De Nicola F, Desantis A et al. NRAGE associates with the anti-apoptotic factor Che-1 and regulates its degradation to induce cell death. J Cell Sci 2007; 120: 1852-1858.
14. Saul VV, de la Vega L, Milanovic M, Kruger M, Braun T, Fritz-Wolf K et al. HIPK2 kinase activity depends on cis-autophosphorylation of its activation loop. J Mol Cell Biol 2013; 91: 1051-1058.
15. Siepi F, Gatti V, Camerini S, Crescenzi M, Soddu S. HIPK2 catalytic activity and subcellular localization are regulated by activation loop Y354 autophosphorylation. Biochem Biophys Acta 2013; 1833: 1443-1453.
16. Kim YH, Choi CY, Lee SJ, Conti MA, Kim Y. Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J Biol Chem 1998; 273: 25875-25879.
17. Calzado MA, Renner F, Roscic A, Schmitz ML. HIPK2: a versatile switchboard regulating the transcription machinery and cell death. Cell Cycle 2007; 15: 139-143.
18. Rinaldo C, Prodosmo A, Siepi F, Soddu S. HIPK2: a multitalented partner for transcription factors in DNA damage response and development. Biochem Cell Biol 2007; 85: 411-418.
19. Calzado MA, De La Vega L, Munoz E, Schmitz ML. From top to bottom: the two faces of HIPK2 for regulation of the hypoxic response. Cell Cycle 2009; 8: 1659-1664.
20. Puca R, Nardinocchi L, Givol D, D'Orazi G. Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells. Oncogene 2010; 29: 4378-4387.
21. D'Orazi G, Cecchinelli B, Bruno T, Mann I, Higashimoto Y, Saito S et al. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat Cell Biol 2002; 4: 11-19.
22. Hofmann TG, Moller A, Sirma H, Zentgraf H, Taya Y, Droge W et al. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat Cell Biol 2002; 4: 1-10.
23. Rinaldo C, Prodosmo A, Mancini F, Iacovelli S, Sacchi A, Moretti F et al. MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis. Mol Cell 2007; 25: 739-750.
24. Di Stefano V, Rinaldo C, Sacchi A, Soddu S, D'Orazi G. Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin-mediated apoptosis. Exp Cell Res 2004; 293: 311-320.
25. Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T et al. P53-AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 2000; 102: 849-862.
26. Pistritto G, Puca R, Nardinocchi L, Sacchi A, D'Orazi G. HIPK2-induced p53Ser46 phosphorylation activates the KILLER/DR5-mediated caspase-8 extrinsic apoptotic pathway. Cell death differ 2007; 14: 1837-1839.
27. Cecchinelli B, Lavra L, Rinaldo C, Iacovelli S, Gurtner A, Gasbarri A et al. Repression of the antiapoptotic molecule galectin-3 by homeodomain-interacting protein kinase 2-activated p53 is required for p53-induced apoptosis. Mol Cell Biol 2006; 26: 4746-4757.
28. Mayo LD, Seo YR, Jackson MW, Smith ML, Rivera Guzman J, Korgaonkar CK et al. Phosphorylation of human p53 at Ser 46 determines promoter selection and whether apoptosis is attenuated or amplified. J Biol Chem 2005; 280: 25953-25959.
29. Zhang Q, Yoshimatsu Y, Hildebrand J, Frisch SM, Goodman RH. Homeodomain interacting protein kinase 2 promotes apoptosis by down-regulating the transcriptional co-repressor CtBP. Cell 2003; 115: 177-186.
30. Lazzari C, Prodosmo A, Siepi F, Rinaldo C, Galli F, Gentileschi M et al. HIPK2 phosphorylates DNp63a and promotes its degradation in response to DNA damage. Oncogene 2011; 30: 4802-4813.
31. Rinaldo C, Prodosmo A, Siepi F, Moncada A, Sacchi A, Selivanova G et al. HIPK2 regulation by MDM2 determines tumor cell response to the p53-reactivating drugs nutlin-3 and RITA. Cancer Res 2009; 69: 62541-62548.
32. Iacovelli S, Ciuffini L, Lazzari C, Bracaglia G, Rinaldo C. Prodosmo A at al. HIPK2 is involved in cell proliferation and its suppression promotes growth arrest independently of DNA damage. Cell Prolif 2009; 42: 373-384.
33. Gresko E, Roscic A, Ritterhoff S, Vichalkovski A, del Sal G, Schmitz ML. Auto-regulatorycontrol of the p53 response by caspase-mediated processing of HIPK2. EMBO J 2006; 25: 1883-1894.
34. Bruno T, Iezzi S, De Nicola F, Di Padova M, Desantis A, Scarsella M et al. Che-1 activates XIAP expression in response to DNA damage. Cell Death and Differ 2007; 15: 515-520.
35. Passananti C, Fanciulli M. The anti-apoptotic factor Che-1/AATF links transcriptional regulation, cell cycle control, and DNA damage response. Cell Div 2007; 2: 21.
36. Hofmann TG, Stolberg N, Schmitz ML, Will H. HIPK2 regulates transforming growth factor-beta-induced c-Jun NH(2)-terminal kinase activation and apoptosis in human hepatoma cells. Cancer Res 2003; 63: 8271-8277.
37. Pierantoni GM, Fedele M, Pentimalli F, Benvenuto G, Pero R, Viglietto G et al. High mobility group. I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth. Oncogene 2001; 20: 6132-6141.
38. Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996; 68: 850-858.
39. Yates JR III, Eng JK, McCormack AL, Schieltz D. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal Chem 1995; 67: 1426-1436.